Filing Details
- Accession Number:
- 0001613377-17-000004
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-02-21 15:31:14
- Reporting Period:
- 2017-02-16
- Filing Date:
- 2017-02-21
- Accepted Time:
- 2017-02-21 15:31:14
- Original Submission Date:
- 2017-02-21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
946644 | Hemispherx Biopharma Inc | HEB | Biological Products, (No Disgnostic Substances) (2836) | 520845822 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1465652 | S. Wayne Springate | 22 St James Court Philadelphia PA 19106 | Sr Vp Of Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-02-16 | 8,014 | $0.46 | 16,641 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The amount of securities beneficially owned following the reported transaction was incorrect when filed earlier today (2/21/17).